Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.

J Am Heart Assoc · 2017 · PMC5721750 · PMID 29118031

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantP =0.053so close (0.05 < p ≤ 0.1)

There was a dose‐dependent increase of pericardial effusion (Table 2 ), whereas there was a numerically modest, borderline significant increase in T2 ratio ( P =0.053).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.